These data suggest that FoxP3-expressing cells characterized by an incomplete epigenetic rearrangement fail to become fully functional Tregs and acquire a Th1-like phenotype, whereby contributing to the immune response against cancer cells. The gene discussed is FOXP3; the disease is cancer.